EyeCheq
EyeCheq provides AI-powered retinal screening kiosks that detect diabetic retinopathy in 5 minutes at point of care, serving community health centers and tribal healthcare systems in rural and underserved US communities.
- Company typePrivate
- Founded2021
- HeadquartersMiami, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What EyeCheq does
EyeCheq is a Miami-based, privately held healthcare technology company founded in 2021 that builds AI-powered, self-guided retinal screening kiosks for point-of-care detection of diabetic retinopathy and other eye diseases. The kiosks perform a 5-minute retinal scan using computer vision and are designed to be deployed in community health centers and tribal healthcare systems, specifically targeting rural and Native American communities that face limited access to specialist ophthalmologists — what the company describes as eye-care deserts. The product positions the retina as a window to broader systemic health, with value-prop messaging around macular degeneration and glaucoma in addition to diabetic retinopathy, supported by an interactive live US disease map on the company website that tracks new diabetes diagnoses and preventable vision loss events in near real-time.
EyeCheq firmographics
Firmographics- Name
- EyeCheq
- Website
- https://eyecheq.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EyeCheq provides AI-powered retinal screening kiosks that detect diabetic retinopathy in 5 minutes at point of care, serving community health centers and tribal healthcare systems in rural and underserved US communities.
- Ownership category
- akta.pro rank
EyeCheq industry classification
Industry- Product category
- Diabetic Retinopathy Screening
- NAICS
- Offices of Optometrists (621320)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Ophthalmology & Vision Telemedicine Platforms (HLALAGAL)
- akta.pro secondary industries
- Comprehensive Eye Exams & Vision Care (HLAKAKAA), Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)
Keywords
Where EyeCheq is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Markets served
EyeCheq business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D
Revenue model
- Vision Screening Services: AI-powered retinal screening services delivered through kiosk deployments in community health centers and tribal healthcare systems for diabetic retinopathy detection and prevention of diabetes-related blindness.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
EyeCheq product offering
Product offeringCore offering
EyeCheq deploys AI-powered, self-guided retinal screening kiosks at the point of care in community health centers and tribal healthcare systems. Each kiosk delivers a 5-minute retinal scan analyzed by computer vision to detect diabetic retinopathy and other eye conditions in asymptomatic, at-risk patients. The platform also publishes a live map of diabetes diagnoses and preventable vision loss events across the United States.
Product overview
EyeCheq offers a single unified product: an AI-powered vision screening kiosk that provides 5-minute retinal screening at the point of care. The kiosk is designed for deployment in underserved areas including rural communities and Native American tribal health systems, addressing eye-care deserts through self-guided screening technology. The platform includes a live mapping feature tracking diabetes diagnoses and preventable vision loss across the United States.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 90% of diabetes-related blindness is preventable with early retinal screening
- +2 more outcomes
Companies that use EyeCheq
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
EyeCheq technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
EyeCheq partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CoPeace HealthcoreStrategic alliance to deploy AI-powered vision screening kiosks in rural and Native American communities to address eye-care deserts. The partnership focuses on increasing access to eye care in underserved areas to prevent blindness caused by diabetes. Deployment utilizes self-guided kiosks in community health centers and tribal healthcare systems.
Scale indicators3 records
Recent moves4 records
Expansion highlights5 records
EyeCheq competitors and assessment
Company assessmentDirect peers
- Digital Diagnostics: Digital Diagnostics developed IDx-DR, the first FDA-cleared autonomous AI system for diabetic retinopathy detection at the point of care. It is the most direct comparator to EyeCheq's autonomous AI retinal screening kiosk model, targeting similar primary-care and underserved settings with specialist-free screening.
- IRIS (Intelligent Retinal Imaging Systems): IRIS is a tele-retinal imaging platform that deploys retinal cameras in primary care and endocrinology practices, with remote specialists reading images to detect diabetic retinopathy. It overlaps directly with EyeCheq's screening-at-point-of-care value proposition and primary-care-first go-to-market.
- AEYE Health: AEYE Health builds AI-based retinal screening solutions for diabetic retinopathy and other ocular conditions, with an FDA clearance pathway and focus on point-of-care use. Its autonomous screening approach and clinical focus closely parallel EyeCheq's AI-powered retinal kiosk model.
- Eyenuk: Eyenuk develops EyeArt, an FDA-cleared AI system for autonomous detection of diabetic retinopathy, deployed in primary care and endocrinology settings. It is a direct functional peer to EyeCheq's autonomous AI retinal screening offering.
- Remidio: Remidio manufactures portable, AI-enabled retinal imaging devices for use in primary care, community health, and resource-limited settings. Its portable screening hardware and underserved-market focus make it highly comparable to EyeCheq's kiosk-based, community-deployment model.
- Optomed: Optomed produces handheld and desktop fundus cameras paired with AI screening software for diabetic retinopathy and other retinal diseases, targeting primary care and screening programs. Its combination of low-cost imaging hardware and AI analytics overlaps directly with EyeCheq's deployment strategy.
Broad incumbents
- Topcon Healthcare: Topcon Healthcare is a large, established ophthalmic device and healthcare-IT vendor offering fundus cameras, screening workflows, and population-health tools used by optometrists and health systems. It competes in the same retinal-screening category as EyeCheq but with a much broader portfolio and traditional clinical-channel focus.
- ZEISS Medical Technology: ZEISS Medical Technology supplies ophthalmic diagnostic devices, imaging platforms, and screening solutions used in clinical eye care globally. While it operates at much greater scale across the ophthalmic value chain, its retinal imaging and screening offerings overlap with the same clinical workflows EyeCheq targets.
Emerging players
- RetinaLyze: RetinaLyze offers cloud-based AI retinal image analysis for diabetic retinopathy and other eye conditions, often integrated with partner fundus cameras. Its narrower scope and earlier commercialization stage make it a partially-overlapping peer to EyeCheq's screening platform.
Regional players
- Orbis International (Cybersight): Orbis operates Cybersight, a tele-ophthalmology platform that connects eye care providers in low- and middle-income countries with specialists for screening, diagnosis, and training. Its global health and underserved-population mission parallels EyeCheq's community/tribal deployment focus, although it operates internationally rather than US-domestically.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks2 records
Key highlights6 records
Customer concentration
EyeCheq social profiles
Digital presenceEyeCheq financial estimates
Financial estimateRevenue estimate
Valuation estimate
EyeCheq leadership team
Management profileNumber of profiles
EyeCheq funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EyeCheq M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EyeCheq
What does EyeCheq do?
EyeCheq deploys AI-powered, self-guided retinal screening kiosks at the point of care in community health centers and tribal healthcare systems. Each kiosk delivers a 5-minute retinal scan analyzed by computer vision to detect diabetic retinopathy and other eye conditions in asymptomatic, at-risk patients. The platform also publishes a live map of diabetes diagnoses and preventable vision loss events across the United States.
Is EyeCheq a public or private company?
EyeCheq is a private company. It is classified as unknown and is currently operating.
When was EyeCheq founded?
EyeCheq was founded in 2021. It employs 11 to 50 people.
Where is EyeCheq based?
EyeCheq is headquartered in Miami, United States, in the North America region.
How does EyeCheq make money?
One revenue line is on record: vision Screening Services.
Who are EyeCheq's main competitors?
Direct peers on record are Digital Diagnostics, IRIS (Intelligent Retinal Imaging Systems), AEYE Health, Eyenuk, Remidio and Optomed. Broad incumbents are Topcon Healthcare and ZEISS Medical Technology. RetinaLyze is listed as an emerging player. Orbis International (Cybersight) is listed as a regional player.
Does EyeCheq have an API?
No public API is recorded for EyeCheq.
What industry is EyeCheq in?
EyeCheq's product category is Diabetic Retinopathy Screening. Its primary akta.pro industry code is HLALAGAL, Ophthalmology & Vision Telemedicine Platforms, with a secondary code of HLAKAKAA, Comprehensive Eye Exams & Vision Care. Its NAICS code is 621320 and its SIC code is 8071.